Oncolytics Biotech Wins FDA Fast Track for Colorectal Cancer Treatment
Oncolytics Biotech receives FDA Fast Track designation for pelareorep in treating KRAS-mutant colorectal cancer, showing promising survival improvements.
Already have an account? Sign in.